Literature DB >> 12547226

Decreased liver hepcidin expression in the Hfe knockout mouse.

Kaashif A Ahmad1, John R Ahmann, Mary C Migas, Abdul Waheed, Robert S Britton, Bruce R Bacon, William S Sly, Robert E Fleming.   

Abstract

Hepcidin is a circulating antimicrobial peptide which has been proposed to regulate the uptake of dietary iron and its storage in reticuloendothelial macrophages. Transgenic mice lacking hepcidin expression demonstrate abnormalities of iron homeostasis similar to Hfe knockout mice and to patients with HFE-associated hereditary hemochromatosis (HH). To identify any association between liver hepcidin expression and the iron homeostasis abnormalities observed in HH, we compared liver hepcidin mRNA content in wild type and Hfe knockout mice. Because the iron homeostasis abnormalities in the Hfe knockout mice are greatest early in life, we analyzed mice at different ages. At four weeks of age, Hfe knockout mice had significantly decreased liver hepcidin mRNA expression compared to wild type mice. The decreased hepcidin expression was associated with hepatic iron deposition, elevated transferrin saturations, and decreased splenic iron concentrations. At 10 weeks of age, despite marked hepatic iron loading, Hfe knockout mice demonstrated liver hepcidin mRNA expression similar to that observed in wild type mice. Placing 8 week-old wild type and Hfe knockout mice on a 2% carbonyl iron diet for 2 weeks led to a similar degree of hepatic iron loading in each group. However, while the wild type mice demonstrated a mean five-fold increase in liver hepcidin mRNA, no change was observed in the Hfe knockout mice. The lack of an increase in liver hepcidin expression in these iron-loaded Hfe knockout mice was associated with sparing of iron deposition into the spleen. These data indicate that the normal relationship between body iron stores and liver hepcidin mRNA levels is altered in Hfe knockout mice, such that liver hepcidin expression is relatively decreased. We speculate that decreased hepcidin expression relative to body iron stores contributes to the iron homeostasis abnormalities characteristic of HH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547226     DOI: 10.1006/bcmd.2002.0575

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  75 in total

1.  Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis.

Authors:  D M Frazer; H R Inglis; S J Wilkins; K N Millard; T M Steele; G D McLaren; A T McKie; C D Vulpe; G J Anderson
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Hepcidin: what every gastroenterologist should know.

Authors:  A P Walker; J Partridge; S K Srai; J S Dooley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.

Authors:  Junwei Gao; Juxing Chen; Ivana De Domenico; David M Koeller; Cary O Harding; Robert E Fleming; Dwight D Koeberl; Caroline A Enns
Journal:  Blood       Date:  2010-02-22       Impact factor: 22.113

Review 4.  Recent advances in intestinal iron transport.

Authors:  Gregory J Anderson; David M Frazer
Journal:  Curr Gastroenterol Rep       Date:  2005-10

5.  Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling.

Authors:  Timothy B Chaston; Pavle Matak; Katayoun Pourvali; Surjit K Srai; Andrew T McKie; Paul A Sharp
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

6.  Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.

Authors:  Marco Constante; Dongmei Wang; Valérie-Ann Raymond; Marc Bilodeau; Manuela M Santos
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Of mice and men: the iron age.

Authors:  Sophie Vaulont; Dan-Qing Lou; Lydie Viatte; Axel Kahn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia.

Authors:  H Kulaksiz; S G Gehrke; A Janetzko; D Rost; T Bruckner; B Kallinowski; W Stremmel
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Authors:  Paul J Schmidt; Iva Toudjarska; Anoop K Sendamarai; Tim Racie; Stuart Milstein; Brian R Bettencourt; Julia Hettinger; David Bumcrot; Mark D Fleming
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  The serine protease TMPRSS6 is required to sense iron deficiency.

Authors:  Xin Du; Ellen She; Terri Gelbart; Jaroslav Truksa; Pauline Lee; Yu Xia; Kevin Khovananth; Suzanne Mudd; Navjiwan Mann; Eva Marie Y Moresco; Ernest Beutler; Bruce Beutler
Journal:  Science       Date:  2008-05-01       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.